AVENUE THERAPEUTICS INC's ticker is and the CUSIP is 05360L304. A total of 15 filers reported holding AVENUE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $38 | – | 32,570 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 264,000 | $306,240 | 0.27% |
| Virtu Financial LLC | 32,570 | $38 | 0.01% |
| Bayesian Capital Management, LP | 11,000 | $12,760 | 0.00% |
| EMFO, LLC | 533 | $618 | 0.00% |
| UBS Group AG | 1,246 | $1,445 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 12 | $14 | 0.00% |
| WELLS FARGO & COMPANY/MN | 4,561 | $5,290 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 11,534 | $13 | 0.00% |
| CITIGROUP INC | 17,321 | $20,092 | 0.00% |